BC Innovations | Apr 29, 2010
Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/ pathway Summary Licensing status Publication and contact information Pulmonary disease Respiratory distress syndrome (RDS) Lysophosphatidylcholine acyltransferase 1 (LPCAT1) A study in mice suggests that increasing LPCAT1 levels could help prevent RDS in infants....
Items per page:
1 - 1 of 1